BNTC insider filings
Benitec Biopharma Inc. — 38 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-06-30. Screen BNTC transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for BNTC between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Benitec Biopharma Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-30 | 4 | BUCHI J KEVIN — Director | Gift (G): 51,813 @ $0 | EDGAR |
| 2026-05-28 | 4 | Friedman David Matthew — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | Mates Sharon — Director | Grant/award (A): 31,500 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | SUVRETTA CAPITAL MANAGEMENT, LLC — Director, 10% owner Cowen Aaron — 10% owner Averill Master Fund, Ltd. — Director, 10% owner Averill Madison Master Fund, Ltd. — Director, 10% owner | Purchase (P): 42,600 @ $12.85 · Purchase (P): 7,400 @ $12.85 · Purchase (P): 14,320 @ $13.10 · Purchase (P): 2,516 @ $13.10 · Purchase (P): 65,800 @ $13.44 · Purchase (P): 11,587 @ $13.44 | EDGAR |
| 2025-12-22 | 4 | SUVRETTA CAPITAL MANAGEMENT, LLC — Director, 10% owner Cowen Aaron — 10% owner Averill Master Fund, Ltd. — Director, 10% owner Averill Madison Master Fund, Ltd. — Director, 10% owner | Purchase (P): 8,700 @ $11.24 · Purchase (P): 1,515 @ $11.24 · Purchase (P): 13,950 @ $11.48 · Purchase (P): 2,434 @ $11.48 · Purchase (P): 16,650 @ $12.08 · Purchase (P): 2,892 @ $12.08 | EDGAR |
| 2025-12-03 | 4 | Mehta Kishan — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | Francis Peter — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | Mates Sharon — Director | Grant/award (A): 3,500 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | Smith Edward F — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | BUCHI J KEVIN — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-11-20 | 4 | Mukadam Sophie — Chief Operating Officer | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2025-11-20 | 4 | Banks Jerel A. — Chief Executive Officer, Director | Grant/award (A): 450,000 (derivative) @ $0 | EDGAR |
| 2025-11-20 | 4 | Boston Megan — Chief Financial Officer, Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | SUVRETTA CAPITAL MANAGEMENT, LLC — Director, 10% owner Averill Madison Master Fund, Ltd. — Director, 10% owner Averill Master Fund, Ltd. — Director, 10% owner Cowen Aaron — 10% owner | Purchase (P): 730,370 @ $13.50 · Purchase (P): 751,111 @ $13.50 | EDGAR |
| 2025-11-07 | 4 | Mates Sharon — Director | Grant/award (A): 28,517 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | SUVRETTA CAPITAL MANAGEMENT, LLC — Director, 10% owner Averill Madison Master Fund, Ltd. — Director, 10% owner Averill Master Fund, Ltd. — Director, 10% owner Cowen Aaron — 10% owner | Purchase (P): 9,503 @ $12.63 · Purchase (P): 1,267 @ $12.63 · Purchase (P): 5,057 @ $13.22 · Purchase (P): 670 @ $13.22 | EDGAR |
| 2025-03-28 | 4 | SUVRETTA CAPITAL MANAGEMENT, LLC — Director, 10% owner Averill Madison Master Fund, Ltd. — Director, 10% owner Averill Master Fund, Ltd. — Director, 10% owner Cowen Aaron — 10% owner | Purchase (P): 793,800 @ $13 · Purchase (P): 106,200 @ $13 | EDGAR |
| 2025-03-13 | 4 | BUCHI J KEVIN — Director | Gift (G): 103,626 @ $0 · Gift (G): 103,626 @ $0 | EDGAR |
| 2025-03-03 | 4 | BUCHI J KEVIN — Director | Option exercise (M): 51,813 @ $3.86 · Option exercise (M): 51,813 (derivative) @ $0 | EDGAR |
| 2024-12-26 | 4 | SUVRETTA CAPITAL MANAGEMENT, LLC — Director, 10% owner Averill Madison Master Fund, Ltd. — Director, 10% owner Averill Master Fund, Ltd. — Director, 10% owner Cowen Aaron — 10% owner | Purchase (P): 24,360 @ $10.98 · Purchase (P): 3,142 @ $10.98 · Purchase (P): 17,730 @ $11.25 · Purchase (P): 2,288 @ $11.25 | EDGAR |
| 2024-12-11 | 4 | Mehta Kishan — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | Banks Jerel A. — Chief Executive Officer, Director | Grant/award (A): 2,310,000 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | Boston Megan — Executive Director, Director | Grant/award (A): 720,000 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | Francis Peter — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | Smith Edward F — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | BUCHI J KEVIN — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2024-12-05 | 4 | SUVRETTA CAPITAL MANAGEMENT, LLC — Director, 10% owner Averill Madison Master Fund, Ltd. — Director, 10% owner Averill Master Fund, Ltd. — Director, 10% owner Cowen Aaron — 10% owner | Purchase (P): 37,190 @ $9.60 · Purchase (P): 4,810 @ $9.60 | EDGAR |
| 2024-11-21 | 4 | SUVRETTA CAPITAL MANAGEMENT, LLC — Director, 10% owner Averill Madison Master Fund, Ltd. — Director, 10% owner Averill Master Fund, Ltd. — Director, 10% owner Cowen Aaron — 10% owner | Purchase (P): 12,430 @ $9.73 · Purchase (P): 1,570 @ $9.73 · Purchase (P): 24,360 @ $10.22 · Purchase (P): 3,076 @ $10.22 | EDGAR |
| 2024-09-30 | 4 | SUVRETTA CAPITAL MANAGEMENT, LLC — Director, 10% owner Averill Madison Master Fund, Ltd. — Director, 10% owner Averill Master Fund, Ltd. — Director, 10% owner Cowen Aaron — Director, 10% owner | Option exercise/expiry (X): 588,236 @ $1.93 · Option exercise/expiry (X): 4,605,000 @ $3.86 · Option exercise/expiry (X): 1,219,970 @ $0.00 · Option exercise/expiry (X): 576,347 @ $3.86 · Option exercise/expiry (X): 148,210 @ $0.00 · Option exercise/expiry (X): 10,000,000 (derivative) @ $0 · +4 more | EDGAR |
| 2024-03-08 | 4 | Banks Jerel A. — Chief Executive Officer, Director | Grant/award (A): 466,554 (derivative) @ $0 | EDGAR |
| 2024-03-08 | 4 | Boston Megan — Executive Director, Director | Grant/award (A): 200,004 (derivative) @ $0 | EDGAR |
| 2023-12-07 | 4 | Francis Peter — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2023-12-07 | 4 | Smith Edward F — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2023-12-07 | 4 | BUCHI J KEVIN — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2023-08-14 | 4 | Boston Megan — Executive Director, Director | Purchase (P): 25,907 · Purchase (P): 25,907 (derivative) | EDGAR |
| 2023-08-14 | 4 | BUCHI J KEVIN — Director | Purchase (P): 51,813 · Purchase (P): 51,813 (derivative) | EDGAR |
| 2023-06-15 | 4 | Boston Megan — Executive Director, Director | Grant/award (A): 153,000 (derivative) @ $0 | EDGAR |
| 2023-06-15 | 4 | Banks Jerel A. — Chief Executive Officer, Director | Grant/award (A): 356,900 (derivative) @ $0 | EDGAR |
Recent 8-K events — Benitec Biopharma Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-05 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-30 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant | EDGAR |
| 2026-09-24 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-29 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-02 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-11-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-07 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BNTC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →